Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

At CDMI 2025, an expert discussed the challenges and potential solutions for adopting digital solutions in clinical trials.

Medical equipment maker Thermo Fisher is nearing an all-cash takeover of U.S-based Clario in a deal that could value the ...

Tamara Murdock, global head of early phase at Emerald Clinical Trials emphasises the importance for sponsors in choosing the ...

The biotech has a deck of RASP modulators. As Aldeyra has accrued evidence in a range of indications, management has shuffled the pack by changing its priority assets in specific diseases. The company ...

In medicine, treatment goals set by physicians might differ from patient priorities. Although normalisation of laboratory parameters is a target supported by outcomes data, patient perspectives ...

Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary ...

UCSF researchers and clinicians presented innovative research and treatment strategies at the American Society of Radiation Oncology’s 2025 Annual Meeting in San Francisco, which ran from Sept. 27 to ...

Greenlight Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated Day 1 and Day 15 dosing schedule for ...

TG Therapeutics, Inc. (NASDAQ: TGTX), announced today that enrollment has completed in the randomized cohort of the Phase 3 ENHANCE trial evaluating a consolidated ...

Total revenues of $1.37 billion in the third quarter of 2025, reflecting 20% growth compared to the third quarter of 2024 ...